Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD

ClinicalTrials.gov ID

NCT07667894

Lead Sponsor

Xinghua LiuOTHER

Overall Status

Recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

500Estimated

Last Update Posted

Sep 10, 2026Actual

Start Date

Jun 29, 2026Actual

Primary Completion Date

May 15, 2028Estimated

Completion Date

May 15, 2028Estimated

Official Title

Effects of an Online Mindfulness-Based Emotion Intervention on Symptoms and Emotional Distress in Patients With Gastroesophageal Reflux Disease: A Multicenter Randomized Waitlist-Controlled Trial

Brief Summary

The goal of this multicenter randomized waitlist-controlled clinical trial is to evaluate whether an online Mindfulness-Based Intervention for Emotional Distress (MIED) can reduce emotional distress and reflux-related symptoms in adults with gastroesophageal reflux disease (GERD). GERD is a common chronic gastrointestinal condition that is frequently accompanied by anxiety, depressive symptoms, stress, and impaired quality of life.

The main questions this study aims to answer are:

Can online MIED reduce emotional distress in patients with GERD?

Can online MIED reduce reflux-related symptoms and improve reflux-related quality of life?

Are changes in psychological processes, such as distress tolerance, cognitive flexibility, experiential avoidance, emotional behaviors, and life engagement, associated with improvements in emotional distress and reflux symptoms?

Researchers will compare participants receiving online MIED with participants in a waitlist control group receiving usual medical care and health management to determine whether online MIED leads to greater improvement over time.

Participants will:

complete screening and baseline assessments;

be randomly assigned to either the online MIED intervention group or the waitlist control group;

if assigned to the intervention group, complete an 8-week online MIED program with one session per week;

continue necessary usual medical care during the study, while keeping medication use stable when possible;

complete online questionnaires at baseline, during the intervention, after the intervention, and at 3, 6, 12, and 24 months after the intervention;

report information on reflux symptoms, emotional distress, quality of life, sleep, stress, resilience, life satisfaction, healthcare use, intervention adherence, and adverse events.

• Gastroesophageal Reflux Disease
• Emotional Distress

• TAU
• MIED

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria

Participants must meet all of the following criteria:

1. Aged 18 to 65 years.
2. GERD-Q score of 8 or higher.
3. Willingness to maintain a relatively stable usual treatment regimen during the study unless medically indicated changes are required.
4. Ability to use a smartphone, computer, or tablet to participate in the online program and complete online questionnaires.
5. Willingness to comply with course training and follow-up assessments.
6. Ability to understand the study and provide written or electronic informed consent.

Exclusion Criteria

Participants meeting any of the following criteria will be excluded:

1. Alarm symptoms or high suspicion of serious organic disease, including but not limited to progressive dysphagia, hematemesis, melena, unexplained weight loss, anemia, recurrent vomiting, or persistent chest pain without exclusion of cardiovascular risk.
2. Current or previous severe esophageal organic disease or gastrointestinal malignancy.
3. History of anti-reflux surgery, partial gastrectomy, or other upper gastrointestinal surgery that may substantially affect reflux symptom assessment.
4. GERD-Q score greater than 15, or symptoms judged by the study physician to be extremely severe and requiring priority medical evaluation or intensified treatment.
5. Current uncontrolled severe mental disorder, such as schizophrenia, manic episode of bipolar disorder, acute severe depressive episode, or severe substance use disorder.
6. Current suicide risk, operationalized as a score greater than 1 on item 9 of the PHQ-9.
7. Previous systematic participation in MIED, mindfulness-based stress reduction, mindfulness-based cognitive therapy, or another structured mindfulness program.

Primary Purpose

Treatment

Allocation

Randomized

Interventional Model

Parallel Assignment

Masking

Double

Lead Sponsor

Xinghua LiuOTHER

13893031337@139.com86+13893031337

1261980387@qq.com86+18931197177

• The Effects and Mechanisms of Mindfulness Intervention for Emotional Distress

  NCT05606224

  Unknown statusInterventionalNot ApplicableUpdated Nov 10, 2022
• Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress

  NCT07280481

  RecruitingInterventionalNot ApplicableUpdated Apr 27, 2026
• Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress: Daily Dairy Research

  NCT05763095

  Unknown statusInterventionalNot ApplicableUpdated Mar 10, 2023
• Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress

  NCT05600790

  Unknown statusInterventionalNot ApplicableUpdated Nov 10, 2022
• The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders

  NCT07458100

  RecruitingInterventionalNot ApplicableUpdated Apr 21, 2026
• The Mechanism of Mindfulness Intervention to Alleviate Emotional Distress in Patients With Emotional Disorders

  NCT05891015

  Unknown statusInterventionalNot ApplicableUpdated Jun 9, 2023